Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-03-09
2009-02-24
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S328000, C424S440000, C424S441000, C424S464000
Reexamination Certificate
active
07494980
ABSTRACT:
A method of preventing biofilm formation in an environment including the steps of administering to the environment an effective amount of a peptide having the amino acid sequence NH2-lys-lys-val-val-phe-lys-val-lys-phe-lys-CONH2[SEQ ID NO: 1] The method is useful in preventing the formation of biofilms in various environments including a home, workplace, laboratory, industrial environment, aquatic environment, animal body or human body. A method of inhibiting the growth of oral microorganisms including the steps of administering to an oral environment an effective amount of a peptide having the amino acid sequence NH2-lys-val-val-phe-lys-val-lys-phe-lys-CONH2[SEQ ID NO: 1].
REFERENCES:
patent: 5989522 (1999-11-01), Friedman
patent: 6365130 (2002-04-01), Barry et al.
patent: 6365635 (2002-04-01), Nomura et al.
patent: 6414035 (2002-07-01), Vargas Munita et al.
patent: 6464962 (2002-10-01), Heckendorn et al.
patent: 6503539 (2003-01-01), Gestrelius et al.
B.F. Gooch, et al. Am. J. Prev. Med. (2002) 23(18), pp. 55-80.
NIH RFA DE-98-006: “Targeted Research on Oral Microbial Biofilms” Mar. 6, 1998.
S.P. Concannon, et al. J. Med. Microbiol. (2003) 52, pp. 1083-1093.
Bateman, Andrew et al., “The Isolation and Identification of Multiple Forms of the Neutrophil Granule Peptides from human Leukemic Cells”, J Biol Chem, Apr. 25, vol. 266, 1991, pp. 7524-7530.
Blondelle, Sylvie E. et al., “Novel Antimicrobial Compounds Identified Using Synthetic Combinatorial Library Technology”, Trends in Biotechnology, 1996, vol. 14, pp. 60-65.
Blondelle, Sylvie E. et al., “Identification of Antimicrobial Peptides by Using Combinatorial Libraries Made Up of Unnatural Amino Acids”, Antimicrobial Agents and Chemotherapy, Oct. 1994, vol. 38, No. 10, pp. 2280-2286.
Blondelle, Sylvie E. et al., “Synthetic Combinatorial Libraries: Novel Discovery Strategy for Identification of Antimicrobial Agents”, Antimicrobial Agents and Chemotherapy, May 1996, vol. 40, No. 5, pp. 1067-1071.
Blondelle, Sylvie E. et al., “Rapid Identification of Compounds with enhanced Antimicrobial Activity by Using Conformationally Defined Combinatorial Libraries”, Biochem. J, 1996, vol. 313, pp. 141-147.
Boggiano, César, “Successful Identification of Novel Agents to Control Infectious Diseases from Screening Mixture-Based Peptide Combinatiorial Libraries in Complex Cell-Based Bioassays”.
Boman, Hans G., “Antibacterial Peptides: Key Componets Needed in Immunity”, Cell, Apr. 19, 1991, vol. 65, pp. 205-207.
Boman, Hans G., “Gene-Encoded Peptide Antibiotics and the Concept of Innate Immunity; An Update Review”, Scand. J. Innunol., 1998, vol. 48, pp. 15-25.
Bowden, G. H. W., “Which Bacteria are Cariogenic in Humans?”, Risk markers for Oral Diseases, vol. 1, Dental Caries, 1991, Cambridge University Press, Cabridge, UK, pp. 266-286.
Chen, Jie et al., “Development of Protegrins for the Treatment and Prevention of Oral Mucositis: Structure-Activity Relationships of Synthetic Protegrin Analogues”, Biopolymers (Peptide Science), 2000, vol. 55, pp. 88-98.
Concannon, Sean P. et al., “Susceptibility of Oral Bacteria to an Antimicrobial Decapeptide”, Journal of Medical Microbiology, 2003, vol. 52, pp. 1083-1093.
Davies, Julian, “Inactivation of Antibiotics and the Dissemination of Resistance Genes”, Science, Apr. 15, 1994, vol. 264, pp. 375-381.
Decker, Thomas et al., “A Quick and Simple Method for the Quantitation of Lactate Dehydorgenase Release in Measurements of Cellular Cytotoxicity and Tumor Necrosis Factor (TNF) Activity”. Journal of Immunological Method, 1988, vol. 15, pp. 61-69.
Donlan, Rodney M. et al, “Biofilms: Survival Mechanisms of Clinically Relevant Microorganims”, Clinical Mirobiology Reviews, Apr. 2002, vol. 15, No. 2, pp. 167-193.
Dyson H. Jane et al., “Defining Solution Conformations of Small Linear Peptides”, Annu. Rev. Biophys. Biophys. Chem., 1991, vol. 20, pp. 519-538.
Elsbach, Peter, “What is the Real Role of Antimicrobial Polypeptides that can Mediate Several Other Inflammatory Responses?”, The Journal of Clinical Investigation, Jun. 2003, vol. 111, No. 11, pp. 1643-1645.
Friedrich, Carol et al., “Salt-Resistant Alpha-Helical Cationic Antimicrobial Peptides”, Antimicrobial Agents and Chemotherapy, Jul. 1999, vol. 43, No. 7, pp. 1542-1548.
Fuchs, Peter C. et al., “In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog”, Antimicrobial Agents and Chemotherapy, May 1998, vol. 42, No. 5, pp. 1213-1216.
Gibbons, R. J., “Role of Adhesion in Microbial Colonization of Host Tissues: A Contribution of Oral Microbiology”, J. Dent Res, 1996, vol. 3, pp. 866-870.
Guthmiller, Janet J. et al., “Susceptibilities of Oral Bacteria and Yeast to Mannalian Cathelicidins”, Antimicrobial Agents and Chemotherapy, Nov. 2001, vol. 45, No. 11, pp. 3216-3219.
Hancock, Robert E. W., “Antibacterial Peptides and the Outer Membranes of Gram-Negative Bacilli”, J. Med. Microbiol (Editorial), 1997, vol. 46, pp. 1-3.
Hancock, Robert E. W., “Peptide Antibiotics”, The Lancet, Feb. 8, 1997, vol. 349, pp. 418-422.
Hancock, Robert E. W. et al., “Cationic Peptides: A New Source of Antibiotics”, TIBTECH, Feb. 1998, vol. 16, pp. 82-88.
Hancock, Robert E. W. et al., “Peptides Antibiotics”, Antimicrobial Agents and Chemotherapy, Jun. 1990, vol. 43, No. 6, pp. 1317-1323.
Hancock, Robert E. W. et al., “Role of Membranes in the Activities of Antimicrobial Cationic Peptides”, FEMS Microbiology Letters 206, 2002, pp. 143-149.
Hancock, Robert E. W. et al., “Cationic Bactericidal Peptides”, Advances in Microbial Physiology, 1995, vol. 37, pp. 135-175.
Helmerhorst, Eva J. et al., “Synthetic Histatin Analogues with Broad-Spectrum Antimicrobial Activity”, Biochem. J., 1997, vol. 325, pp. 39-45.
Helmerhorst, Eva J. et al., “The Effects of Histatin-Derived Basic Antimicrobial Peptides on Oral Biofilms”, J. Dent Res, Jun. 1999, vol. 78, No. 6, pp. 1245-1250.
Henderson et al., “Bacteria-Cytokine Interactions in Health and Disease”, Portland Press, pp. 351-354.
Hong, Sung Y. et al., Identification and Characterization of Novel Antimicrobial Decapeptides Generated by Combinatiorial Chemotherapy, Oct. 1998, vol. 42, No. 10, pp. 2534-2541.
Kaiser, E. et al., “Color Test for Detection of Free Terminal Amino Groups in the Solid-Phase Synthesis of Peptides”, Short Communications, Oct. 1969, pp. 595-599.
Kilian, Mogens et al., “Taxonomic Study of Viridans Streptococci: Description ofStretococcus gordoniisp. Nov. and Emended Descriptions ofStreptococcus sanguis(White and Niven 1946),Streptococcus oralis(Bridge and Sneath 1982), andStreptococcus mitis(Andrewes and Hordes 1906)”, International Journal of Systematic Bacterilogy, Oct. 1989, vol. 39, No. 4, pp. 471-484.
Koczulla, Andreas R. et al., “Antimicrobial Peptides—Current Status and Therapeutic Potential”, Drugs, 2003, Vo. 63, No. 4, pp. 389-406.
Koczulla, Rembert et al., “An Angiogenic Role for the Human Peptide Antibiotic LL-37/hCAP-18”, The Journal of Clinical Investigation, Jun. 2003, vol. 111, No. 11, pp. 1665-1672.
Kolenbrander, Paul E., “Adhere Today, Here Tomorrow; Oral Bacterial Adherence”, Journal of Bacteriology, Jun. 1993, vol. 175, No. 11. pp. 3247-3252.
Kolenbrander, Paul E., “Coaggregation: Specific Adherence Among Human Oral Plaque Bacteria”, The FAEB Journal, Mar. 1993, vol. 7, pp. 406-413.
Lee, In Hee et al., “Effects of pH and Salinity on the Antimicrobial Properties of Clavanins”, Infection and Immunity, Jul. 1997, vol. 65, No. 7, pp. 2898-2903.
Lisle, John T. et al., “Fluorescent Probes Applied to Physiological Charcterization of Bacterial Biolfilms”, Methods in Enzymology, 1999,
Concannon Sean P
Leung Kai P
Arwine Elizabeth
Kosar Andrew D
The United States of America as represented by the Secretary of
LandOfFree
Antimicrobial peptide and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial peptide and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial peptide and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4063086